NovoLog - 0169-6339-10 - (insulin aspart)

Alphabetical Index


Drug Information of NovoLog

Product NDC: 0169-6339
Proprietary Name: NovoLog
Non Proprietary Name: insulin aspart
Active Ingredient(s): 100    [iU]/mL & nbsp;   insulin aspart
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of NovoLog

Product NDC: 0169-6339
Labeler Name: Novo Nordisk
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020986
Marketing Category: NDA
Start Marketing Date: 20030122

Package Information of NovoLog

Package NDC: 0169-6339-10
Package Description: 5 SYRINGE, PLASTIC in 1 CARTON (0169-6339-10) > 3 mL in 1 SYRINGE, PLASTIC

NDC Information of NovoLog

NDC Code 0169-6339-10
Proprietary Name NovoLog
Package Description 5 SYRINGE, PLASTIC in 1 CARTON (0169-6339-10) > 3 mL in 1 SYRINGE, PLASTIC
Product NDC 0169-6339
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name insulin aspart
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20030122
Marketing Category Name NDA
Labeler Name Novo Nordisk
Substance Name INSULIN ASPART
Strength Number 100
Strength Unit [iU]/mL
Pharmaceutical Classes Insulin [Chemical/Ingredient],Insulin Analog [EPC]

Complete Information of NovoLog


General Information